Physician profile
Eric Melchior
NPI 1932524758
$2,524.22
in general payments reported to CMS, 2019-2025
10 companies · $642 in 2025
The $642 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $26.98 · 2024: $1,856 · 2025: $642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,573 · Food and Beverage: $733 · Education: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,572.85 |
| Food and Beverage | $732.96 |
| Education | $191.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,769.88 | 2024 | |
| Baxter Healthcare | $289.93 | 2024-2025 | Perclot |
| Kerecis Limited | $171.03 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Medtronic, INC. | $122.68 | 2025 | Progrip |
| Acera Surgical, INC. | $50.02 | 2025 | Restrata Wound Matrix |
| Integra Lifesciences Corporation | $45.21 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $30.78 | 2024 | Collagenase Santyl |
| Conmed Corporation | $17.71 | 2024 | Airseal |
| Convatec INC. | $15.54 | 2020 | |
| Acell, INC. | $11.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Melchior listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.